Patents by Inventor Chunyan Hao

Chunyan Hao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240107850
    Abstract: A display substrate and a display apparatus. The display substrate has a display region (AA) and an opening (O) located in the display region (AA). The opening (O) penetrates the display substrate, and the display substrate comprises a base substrate (BS), a driving circuit layer, a light-emitting device layer, an encapsulation layer and a touch layer (TL). The driving circuit layer is arranged on the base substrate (BS), and comprises a first signal line (L1) at least partially surrounding the opening (O). The light-emitting device layer is arranged on the side of the driving circuit layer distant from the base substrate (BS). The encapsulation layer is arranged on the side of the light-emitting device layer distant from the base substrate (BS).
    Type: Application
    Filed: July 6, 2022
    Publication date: March 28, 2024
    Inventors: Jingjing XU, Xueguang HAO, Chunyan LI, Lang LIU, Jingquan WANG
  • Publication number: 20220387435
    Abstract: The present invention provides use of a multi-target protein kinase inhibitor compound A or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating leukemia, and provides a method for treating acute myeloid leukemia, especially acute myeloid leukemia with FLT3 mutation, with compound A. In clinical trials, compound A has certain efficacies both on acute myeloid leukemia with FLT3-ITD mutation and/or FLT3-TKD mutation, and on DEK-CAN positive acute myeloid leukemia with FLT3-ITD mutation. Patients with relapsed and/or refractory acute myeloid leukemia who have failed treatment previously with Type II FLT3 inhibitors (e.g., sorafenib) can still clinically benefit from the treatment with compound A.
    Type: Application
    Filed: November 9, 2020
    Publication date: December 8, 2022
    Applicant: CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
    Inventors: Yueying Peng, Guoning Zhan, Xiaojing Li, Chunyan Hao, Xuemin Zhao, Wei Hu